Physician characteristics associated with treatment initiation patterns in idiopathic pulmonary fibrosis

Pirfenidone and nintedanib are oral antifibrotic agents approved for the treatment of idiopathic pulmonary fibrosis (IPF). Real-world data on factors that influence IPF treatment decisions are limited. Physician characteristics associated with antifibrotic therapy initiation following an IPF diagnos...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chron Respir Dis
Main Authors: LaCamera, Peter P, Limb, Susan L, Haselkorn, Tmirah, Morgenthien, Elizabeth A, Stauffer, John L, Wencel, Mark L
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6764076/
https://ncbi.nlm.nih.gov/pubmed/31558049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479973119879678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados